Special Issues in the Diagnosis and Treatment of ADHD in Adolescents

References

• Biederman J, Faraone SV. Attention-deficit hyperactivity disorder. Lancet. 2005; 366(9481): 237–248.
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics. Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics. 2000; 105(5): 1158–1170.
   PubMed Web of Science ®Google Scholar
• Greenhill LL, Pliszka S, Dulcan MK; American Academy of Child and Adolescent Psychiatry. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry. 2002; 41(10): 25S–49S.
   Google Scholar
• Pliszka SR, Crismon ML, Hughes CW, et al; Texas Consensus Conference Panel on Pharmacotherapy of Childhood Attention Deficit Hyperactivity Disorder. The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2006; 45(6): 642–657.
   PubMed Web of Science ®Google Scholar
• Biederman J, Mick E, Faraone SV. Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am J Psychiatry. 2000; 157(5): 816–818.
   PubMed Web of Science ®Google Scholar
• Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med. 2006; 36(2): 159–165.
   PubMed Web of Science ®Google Scholar
• Applegate B, Lahey BB, Hart EL, et al. Validity of the age-of-onset criterion for ADHD: a report from the DSM-IV field trials. J Am Acad Child Adolesc Psychiatry. 1997; 36(9): 1211–1221.
   PubMed Web of Science ®Google Scholar
• Weiss G. Followup studies on outcome of hyperactive children. Psychopharmacol Bull. 1985; 21(2): 169–177.
   PubMedGoogle Scholar
• Weiss G, Minde K, Werry JS, Douglas V, Nemeth E. Studies on the hyperactive child. 8. Five-year follow-up. Arch Gen Psychiatry. 1971; 4(5): 409–414.
   Google Scholar
• Gittelman R, Mannuzza S, Shenker R, Bonagura N. Hyperactive boys almost grown up. I. Psychiatric status. Arch Gen Psychiatry. 1985; 42(10): 937–947.
   PubMed Web of Science ®Google Scholar
• Barkley RA, Anastopoulos AD, Guevremont DC, Fletcher KE. Adolescents with ADHD: patterns of behavioral adjustment, academic functioning, and treatment utilization. J Am Acad Child Adolesc Psychiatry. 1991; 30(5): 752–761.
   PubMed Web of Science ®Google Scholar
• Rappley MD. Clinical practice. Attention deficit-hyperactivity disorder. N Engl J Med. 2005; 352(2): 165–173.
   PubMed Web of Science ®Google Scholar
• Conners CK., Sitarenios G, Parker JD, Epstein JN. The revised Conners' Parent Rating Scale (CPRS-R): factor structure, reliability, and criterion validity. J Abnorm Child Psychol. 1998; 26(4): 257–268.
   PubMed Web of Science ®Google Scholar
• Conners CK, Sitarenios G, Parker JD, Epstein JN. Revision and restandardization of the Conners Teacher Rating Scale (CTRS-R): factor structure, reliability, and criterion validity. J Abnorm Child Psychol. 1998; 26(4): 279–291.
   PubMed Web of Science ®Google Scholar
• Wolraich ML, Wibbelsman CJ, Brown TE, et al. Attention-deficit disorder among adolescents: a review of the diagnosis, treatment, and clinical implications. Pediatrics. 2005; 115(6): 1734–1746.
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics. Subcommittee on Attention-Deficit/Hyperactivity Disorder and Committee on Quality Improvement. Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics. 2001; 108(4): 1033–1044.
   PubMedGoogle Scholar
• Pliszka SR. Psychiatric comorbidities in children with attention deficit hyperactivity disorder: implications for management. Pediatr Drugs. 2003; 5(11): 741–750.
   PubMedGoogle Scholar
• Biederman J, Monuteaux MC, Mick E, et al. Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study. Psychol Med. 2006; 36(2): 167–179.
   PubMed Web of Science ®Google Scholar
• Pliszka S; AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007; 46(7): 894–921.
   PubMed Web of Science ®Google Scholar
• Wilson JJ, Levin FR. Attention-deficit/hyperactivity disorder and early-onset substance use disorders. J Child Adolesc Psychopharmacol. 2005; 5(5): 751–763.
   Google Scholar
• Fergusson DM, Horwood LJ, Lynskey MT. Prevalence and comorbidity of DSM-III-R diagnoses in a birth cohort of 15-year-olds. J Am Acad Child Adolesc Psychiatry. 1993; 32(6): 1127–1134.
   PubMedGoogle Scholar
• Fischer M, Barkley RA, Smallish L, Fletcher K. Young adult follow-up of hyperactive children: self-reported psychiatric disorders, comorbidity, and the role of childhood conduct problems and teen CD. J Abnorm Child Psychol. 2002; 30(5): 463–475.
   PubMed Web of Science ®Google Scholar
• Wilens TE, Biederman J, Mick E, Faraone SV, Spencer T. Attention deficit hyperactivity disorder (ADHD) is associated with early onset substance use disorders. J Nerv Ment Dis. 1997; 185(8): 475–482.
   PubMed Web of Science ®Google Scholar
• Milberger S, Biederman J, Faraone SV, Chen L, Jones J. ADHD is associated with early initiation of cigarette smoking in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1997; 36(1): 37–14.
   PubMed Web of Science ®Google Scholar
• Lambert N, Hartsough C. Prospective study of tobacco smoking and substance dependence among samples of ADHD and non-ADHD participants. J Learn Disabil. 1998; 31(6): 533–544.
   PubMed Web of Science ®Google Scholar
• Wilens TE, Biederman J. Alcohol, drugs, and attention-deficit/ hyperactivity disorder: a model for the study of addictions in youth. J Psychopharmacol. 2006; 20(4): 580–588.
   PubMed Web of Science ®Google Scholar
• Schubiner H, Tzelepis A, Milberger S. Prevalence of attention deficit hyperactivity disorder and conduct disorder among substance abusers. J Clin Psychiatry. 2000; 61(4): 244–251.
   PubMed Web of Science ®Google Scholar
• Wilens T. Alcohol and other drug use and attention deficit hyperactivity disorder. Alcohol Health Res World. 1998; 22: 127–130.
   PubMedGoogle Scholar
• Masi G, Millepiedi S, Mucci M, Bertini N, Pfanner C, Arcangeli F. Comorbidity of obsessive-compulsive disorder and attention-deficit/hyperactivity disorder in referred children and adolescents. Compr Psychiatry. 2006; 47(1): 42–47.
   PubMed Web of Science ®Google Scholar
• Connor DF, Edwards G, Fletcher KE, Baird J, Barkley RA, Steingard RJ. Correlates of comorbid psychopathology in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2003; 42(2): 193–200.
   PubMed Web of Science ®Google Scholar
• Birmaher B, Ryan ND, Williamson DE, et al. Childhood and adolescent depression: a review of the past ten years. Part I. J Am Acad Child Adolesc Psychiatry. 1996; 35(11): 1427–1439.
   PubMed Web of Science ®Google Scholar
• Angold A, Costello EJ, Worthman CM. Puberty and depression: the roles of age, pubertal status and pubertal timing. Psychol Med. 1998; 28(1): 51–61.
   PubMed Web of Science ®Google Scholar
• Biederman J, Newcorn J, Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry. 1991; 148(5): 564–577.
   PubMed Web of Science ®Google Scholar
• Leibenluft E, Charney DS, Towbin KE, Bhangoo RK, Pine DS. Defining clinical phenotypes of juvenile mania. Am J Psychiatry. 2003; 60(3): 430–437.
   Google Scholar
• Harpin VA. The effect of ADHD on the life of an individual, their family, and community from preschool to adult life. Arch Dis Child. 2005; 90(suppl I): i2–i7.
   PubMedGoogle Scholar
• Friedman SR, Rapport LJ, Lumley M, et al. Aspects of social and emotional competence in adult attention-deficit/hyperactivity disorder. Neuropsychology. 2003; 17(1): 50–58.
   PubMed Web of Science ®Google Scholar
• Meitzer H, Gatward R, Goodman R, et al. The Mental Health of Children and Adolescents in Great Britain. London, England: Office of National Statistics, the Stationery 0ffice;2000.
   Google Scholar
• Topolski TD, Edwards TC, Patrick DL, Varley P, Way ME, Buesching DP. Quality of life of adolescent males with attention-deficit hyperactivity disorder. J Atten Disord. 2004; 7(3): 163–173.
   PubMedGoogle Scholar
• Wilens TE, McBurnett K, Bukstein O, et al. Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med. 2006; 160(1): 82–90.
   PubMedGoogle Scholar
• McGough JJ, McBurnett K, Bukstein O, et al. Once-daily OROS methylphenidate is safe and well tolerated in adolescents with attention- deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2006; 16(3): 351–356.
   PubMed Web of Science ®Google Scholar
• Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read S, Pratt R. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. Clin Ther. 2006; 28(2): 266–279.
   PubMed Web of Science ®Google Scholar
• Michelson D, Faries D, Wernicke J, et al. Atomoxetine in the treatment of children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled, dose-response study. Pediatrics. 2001; 108(5): E83.
   PubMed Web of Science ®Google Scholar
• Cox DJ, Merkel RL, Kovatchev B, Seward R. Effect of stimulant medication on driving performance of young adults with attention-deficit hyperactivity disorder. J Nerv Ment Dis. 2000; 188(4): 230–234.
   PubMed Web of Science ®Google Scholar
• Cox DJ, Humphrey JW, Merkel RL, et al. Controlled-release methylphenidate improves attention during on-road driving by adolescents with attention-deficit/hyperactivity disorder. J Am Board Fam Pract. 2004; 17(4): 235–239.
   PubMedGoogle Scholar
• Cox DJ, Merkel RL, Moore M, Thorndike F, Muller C, Kovatchev B. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder. Pediatrics. 2006; 118(3): e704–e710.
   PubMed Web of Science ®Google Scholar
• Zhang HF, Cooper KM. OROS®: MPH significantly improves family relations in adolescents. Presented at the 18th Annual US Psychiatric and Mental Health Congress; Las Vegas, NV; November 8, 2005.
   Google Scholar
• Frankel F, Cantwell DP, Myatt R, Feinberg DT. Do stimulants improve self-esteem in children with ADHD and peer problems? J Child Adolesc Psychopharmacol. 1999 (3); 9: 185–194.
   PubMed Web of Science ®Google Scholar
• Hechtman L, Greenfield B. Long-term use of stimulants in children with attention deficit hyperactivity disorder. Pediatr Drugs. 2003; 5(12): 787–794.
   PubMedGoogle Scholar
• Biederman J. Pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) decreases the risk for substance abuse: findings from a longitudinal follow-up of youths with and without ADHD. J Clin Psychiatry. 2003; 64(suppl 11): 3–8.
   PubMed Web of Science ®Google Scholar
• Faraone SV, Wilens T. Does stimulant treatment lead to substance use disorders? J Clin Psychiatry. 2003; 11(suppl 64): 9–13.
   Google Scholar
• Katusic SK, Barbaresi WJ, Colligan RC, Weaver AL, Leibson CL, Jacobsen SJ. Psychostimulant treatment and risk for substance abuse among young adults with a history of attention-deficit/hyperactivity disorder: a population-based, birth cohort study. J Am Acad Child Adolesc Psychiatry. 2005; 15(5): 764–776.
   Google Scholar
• DuPont RL, Bensinger PB. Abuse-resistant drug delivery. Psychiatr Ann. 2005; 35(8): 253–256.
   Web of Science ®Google Scholar
• Wolraich ML, Greenhill LL, Pelham W, et al. Randomized, controlled trial of OROS methylphenidate once a day in children with attention- deficit/hyperactivity disorder. Pediatrics. 2001; 108(4): 883–892.
   PubMed Web of Science ®Google Scholar
• Wilens T, Faraone S, Biederman J, Gunawardene S. Does stimulant therapy of ADHD beget later substance abuse: a meta-analytic review of the literature. Pediatrics. 2003; 11(1): 179–185.
   Google Scholar
• Greenhill LL, Halperin JM, Abikoff H. Stimulant medications. J Am Acad Child Adolesc Psychiatry. 1999; 38(5): 503–512.
   PubMed Web of Science ®Google Scholar
• Smith BH, Pelham WE Jr, Gnagy E, Molina B, Evans S. The reliability, validity, and unique contributions of self-report by adolescents receiving treatment for attention-deficit/hyperactivity disorder. J Consult Clin Psychol. 2000; 68: 489–499.
   PubMed Web of Science ®Google Scholar
• McBurnett K, Elliott G, Pfiffner L, et al. OROS® MPH in adolescents with ADHD: validity of patient self-assessments. Presented at the 158th Annual Meeting of the American Psychiatric Association; Atlanta, GA; May 24, 2005.
   Google Scholar
• Zhang HF, Cooper KM. Physician-rated and patient-reported ADHD symptom improvement with OROSTM MPH treatment in adolescents. Presented at the 18th Annual US Psychiatric and Mental Health Congress; Las Vegas, NV; November 8, 2005.
   Google Scholar